Effects of Concurrent Administration of BVDV Modified Live Viral Vaccine and RB51 on Immune Responses in Cattle
Open Access
Abstract
Cell-mediated immunity is an important component of the immune response for intracellular pathogens. Live vaccines containing different pathogens are used concurrently in the field but are generally licensed individually. Concurrent administration of these vaccines has led to concerns about immune interference. The goal of this study was to characterize BVDV-specific responses to vaccination and determine the effect of concurrent Brucella abortus strain RB51 (RB51) vaccine administration. Peripheral blood mononuclear cells (PBMCs) from cattle vaccinated with a modified-live viral (MLV) vaccine containing BVDV, both RB51 and an MLV, or unvaccinated controls were utilized to evaluate antibody titers and the frequency of interferon gamma (IFN-γ) production within CD4+, CD8+ T cells, and NK cell populations via flow-cytometry. Our data demonstrated the lack of vaccine interference following concurrent administration of two common bovine MLVs and may even suggest some level of enhanced IFN-γ production with concurrent administration.Keywords
Funding Information
- U.S. Department of Agriculture, Agricultural Research Service Project CRIS (3625-32000-222)
This publication has 23 references indexed in Scilit:
- Targeting natural killer cells to enhance vaccine responsesTrends in Pharmacological Sciences, 2021
- Regulation of the human NK cell compartment by pathogens and vaccinesClinical & Translational Immunology, 2021
- Changes in circulating lymphocytes and lymphoid tissue associated with vaccination of colostrum deprived calvesVaccine, 2020
- Multivariate analysis as a method to evaluate antigenic relationships between BVDV vaccine and field strainsVaccine, 2020
- Measuring CMI responses using the PrimeFlow RNA assay: A new method of evaluating BVDV vaccination response in cattleVeterinary Immunology and Immunopathology, 2020
- Comparison of reproductive protection against bovine viral diarrhea virus provided by multivalent viral vaccines containing inactivated fractions of bovine viral diarrhea virus 1 and 2Vaccine, 2018
- Antibody titers to vaccination are not predictive of level of protection against a BVDV type 1b challenge in Bos indicus - Bos taurus steersVaccine, 2016
- Boosting vaccine efficacy the natural (killer) wayTrends in Immunology, 2015
- Immunology of BVDV vaccinesBiologicals, 2013
- Bovine natural killer cellsVeterinary Immunology and Immunopathology, 2009